Go Hearing Go Prime vs Lexie B3

The Go Hearing Go Prime is a budget-priced OTC hearing aid available for $299, earning a B grade with a SoundScore of 3.3/5 in our lab testing. This visible-in-ear style device with rechargeable batteries ranks #50 of 65 OTC hearing aids tested, placing it in the top 75% of its category. In our testing, the Go Prime delivered mixed results across performance metrics. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users can expect stable amplification without whistling during typical daily activities. However, speech clarity showed more modest performance, with speech in quiet scoring 2.7/5 and speech in noise at 1.1/5, both falling slightly below category averages. The device's most significant limitation is music streaming, which scored 0.0/5 in our testing—nearly 2 points below the category average. Users who prioritize phone audio streaming for calls or media should consider alternatives. Own-voice comfort also scored low at 1.8/5, which may result in a "boomy" quality when speaking. At its $299 price point, the Go Prime faces stiff competition. Higher-scoring alternatives in the same price range include the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5). Budget-conscious shoppers might also consider the Olive Union Max or Lucid Enrich Pro, which offer comparable or better sound scores at lower prices. The Go Prime may suit those who prioritize feedback-free amplification and don't need streaming functionality, but most buyers would benefit from exploring these alternatives.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.